These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 20921386)
1. Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome. Wu H; Tao J; Chen PJ; Shahab A; Ge W; Hart RP; Ruan X; Ruan Y; Sun YE Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18161-6. PubMed ID: 20921386 [TBL] [Abstract][Full Text] [Related]
2. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Urdinguio RG; Fernandez AF; Lopez-Nieva P; Rossi S; Huertas D; Kulis M; Liu CG; Croce CM; Calin GA; Esteller M Epigenetics; 2010 Oct; 5(7):656-63. PubMed ID: 20716963 [TBL] [Abstract][Full Text] [Related]
3. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling. Mellios N; Feldman DA; Sheridan SD; Ip JPK; Kwok S; Amoah SK; Rosen B; Rodriguez BA; Crawford B; Swaminathan R; Chou S; Li Y; Ziats M; Ernst C; Jaenisch R; Haggarty SJ; Sur M Mol Psychiatry; 2018 Apr; 23(4):1051-1065. PubMed ID: 28439102 [TBL] [Abstract][Full Text] [Related]
4. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome. Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047 [TBL] [Abstract][Full Text] [Related]
5. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes. Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767 [TBL] [Abstract][Full Text] [Related]
6. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996 [TBL] [Abstract][Full Text] [Related]
7. Mecp2-null mice provide new neuronal targets for Rett syndrome. Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361 [TBL] [Abstract][Full Text] [Related]
8. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282 [TBL] [Abstract][Full Text] [Related]
9. Regulation, diversity and function of MECP2 exon and 3'UTR isoforms. Rodrigues DC; Mufteev M; Ellis J Hum Mol Genet; 2020 Sep; 29(R1):R89-R99. PubMed ID: 32681172 [TBL] [Abstract][Full Text] [Related]
10. Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model. Petazzi P; Sandoval J; Szczesna K; Jorge OC; Roa L; Sayols S; Gomez A; Huertas D; Esteller M RNA Biol; 2013 Jul; 10(7):1197-203. PubMed ID: 23611944 [TBL] [Abstract][Full Text] [Related]
11. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients. Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913 [TBL] [Abstract][Full Text] [Related]
12. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism. Swanberg SE; Nagarajan RP; Peddada S; Yasui DH; LaSalle JM Hum Mol Genet; 2009 Feb; 18(3):525-34. PubMed ID: 19000991 [TBL] [Abstract][Full Text] [Related]
14. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. Jordan C; Li HH; Kwan HC; Francke U BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923 [TBL] [Abstract][Full Text] [Related]
15. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome. Miyake K; Hirasawa T; Soutome M; Itoh M; Goto Y; Endoh K; Takahashi K; Kudo S; Nakagawa T; Yokoi S; Taira T; Inazawa J; Kubota T BMC Neurosci; 2011 Aug; 12():81. PubMed ID: 21824415 [TBL] [Abstract][Full Text] [Related]
16. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Peddada S; Yasui DH; LaSalle JM Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435 [TBL] [Abstract][Full Text] [Related]
17. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Chang Q; Khare G; Dani V; Nelson S; Jaenisch R Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138 [TBL] [Abstract][Full Text] [Related]
19. Rett syndrome and MeCP2. Liyanage VR; Rastegar M Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633 [TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. Ogier M; Wang H; Hong E; Wang Q; Greenberg ME; Katz DM J Neurosci; 2007 Oct; 27(40):10912-7. PubMed ID: 17913925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]